isoxazoles has been researched along with thromboxane b2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breslow, R; Cheng, JB; Conklyn, MJ; Pillar, JS; Shirley, JT; Showell, HJ | 1 |
| Kent, JD; Leese, PT; Recker, DP; Talwalker, S | 1 |
| Kent, JD; Leese, PT; Recker, DP | 1 |
| Di Nunno, L; Patrignani, P; Scilimati, A; Tacconelli, S; Vitale, P | 1 |
| Munsterhjelm, E; Neuvonen, PJ; Niemi, TT; Rosenberg, PH; Ylikorkala, O | 1 |
| Arabmotlagh, M; Cheung, R; Geisslinger, G; Graff, J; Harder, S | 1 |
| Ahmad, M; Graham, SH; Liu, H; Rose, ME; Zhang, Y | 1 |
| Archer, TM; Mackin, AJ; Thomason, JM; Wills, RW | 1 |
5 trial(s) available for isoxazoles and thromboxane b2
| Article | Year |
|---|---|
Valdecoxib does not impair platelet function.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Bleeding Time; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Naproxen; Platelet Aggregation; Statistics, Nonparametric; Sulfonamides; Thromboxane B2 | 2002 |
The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Arachidonic Acid; Bleeding Time; Blood Platelets; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Ibuprofen; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane B2 | 2003 |
Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers.
Topics: Acetaminophen; Adenosine Diphosphate; Adult; Analgesics, Non-Narcotic; Arachidonic Acid; Blood Platelets; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Epinephrine; Humans; Infusions, Intravenous; Isoxazoles; Male; Platelet Aggregation; Thromboxane B2 | 2006 |
Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Child; Cyclooxygenase Inhibitors; Dipyrone; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Isoxazoles; Male; Middle Aged; Pain, Postoperative; Platelet Aggregation; Thromboxane B2 | 2007 |
Effects of immunosuppressive agents on the hemostatic system in normal dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azathioprine; Blood Coagulation; Blood Platelets; Creatinine; Cross-Over Studies; Cyclosporine; Dogs; Female; Hemostasis; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Platelet Aggregation; Platelet Count; Prednisone; Thromboxane B2 | 2018 |
3 other study(ies) available for isoxazoles and thromboxane b2
| Article | Year |
|---|---|
Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
Topics: Animals; Antigens; Guinea Pigs; Immunoglobulin G; Indazoles; Isoxazoles; Lung; Male; Platelet Activating Factor; SRS-A; Thromboxane B2 | 1990 |
Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
Topics: Adult; Biochemistry; Blood; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Inhibitory Concentration 50; Isoenzymes; Isoxazoles; Lipopolysaccharides; Membrane Proteins; Monocytes; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Sulfonamides; Thromboxane B2 | 2004 |
Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity.
Topics: Animals; Blood Pressure; Body Temperature; Brain; Cerebrovascular Circulation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Hippocampus; Infarction, Middle Cerebral Artery; Isoxazoles; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sulfonamides; Thromboxane B2; Time Factors | 2009 |